NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
53 hedge funds and large institutions have $53.6M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-15
Holders Change %
-22.06%
% of All Funds
1.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
6
Increased
9
Reduced
15
Closed
21
Calls
–
Puts
$110K
Net Calls
-$110K
Net Calls Change
-$30K
Top Buyers
| 1 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$1.15M |
| 2 |
Millennium Management
New York
|
+$1.09M |
| 3 |
Goldman Sachs
New York
|
+$762K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$271K |
| 5 |
ECM
Element Capital Management
New York
|
+$226K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.35M |
| 2 |
State Street
Boston,
Massachusetts
|
-$768K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$465K |
| 4 |
O
OrbiMed
New York
|
-$350K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$247K |
